Popular Articles
Revitol Cellulite Cream

Olympus Broadens Portfolio With New Biliary Metallic Stent
Olympus America Inc. has expanded its medical portfolio by introducing the X-Suit NIR®, a biliary metallic stent designed with exceptional anatomic conformability and superior radial support. The X-Suit NIR"s proprietary NIRflex™ cell design provides a physician support and flexibility; both critical to help relieve the symptoms associated with pancreatic, liver and bile duct cancers. Don't forget to buy zoloft online no prescription.

FDA Approves Expanded Use Of HIV Drug
Merck announced on Thursday that the FDA has approved expanded use of its HIV drug, Isentress, Reuters reports (Pierson, 7/9). Isentress has been FDA-approved since 2007, but was limited "to use in patients who had drug-resistant strains or were failing on other therapies, also in combination with other HIV drugs. Now it can be used in all adult patients," the AP/CNBC.com reports. According to AP/CNBC.com, "Isentress is an integrase inhibitor, meaning it works by blocking the enzyme integrase, one of three types of enzymes the AIDS virus uses to reproduce and infect cells" (7/9).

generic viagra online


News of the day
FDA Approves Plan B(R) One-Step, A New One-Pill Emergency Contraceptive
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Plan B® One-Step emergency contraception (levonorgestrel tablet, 1.5 mg). Now, with new Plan B® One-Step, women can help prevent an unintended pregnancy after unprotected sex or contraceptive failure with just one pill in one dose. The FDA is expanding over-the-counter (OTC) access to Plan B® One-Step for consumers age 17 or older; women younger than age 17 will require a prescription. The product will be available at licensed U.S. retail pharmacies within the next month.
Oncology

Colorectal Cancer Rates Increasing Worldwide, According To Study

A new study finds colorectal cancer incidence rates for both males and females increased in 27 of 51 countries worldwide between 1983 and 2002, and points to increasing Westernization as being a likely culprit. The rise was seen primarily in economically transitioning countries including Eastern European countries, most parts of Asia, and some countries of South America. The study is the first in a peer-reviewed journal to present colorectal cancer incidence trends across all five continents. It appears in the June 2009 issue of Cancer Epidemiology Biomarkers and Prevention. An accompanying editorial says the rise points toward a failed early detection and prevention strategy as well as failure to address lifestyle and dietary challenges of urbanization that affect most of the globe. Colorectal cancer is the fourth most common cancer in men and the third most common cancer in women worldwide. Previous studies have reported rapid increases in colorectal cancer incidence rates in economically transitioning countries in many parts of the world, likely reflecting changing dietary and physical activity patterns. However, those studies used old data and examined regional or country-specific trends. The new study, led by American Cancer Society epidemiologist Melissa Center, MPH, reviewed colorectal cancer incidence data from 51 cancer registries worldwide with long-term incidence data from the Cancer Incidence in Five Continents (CI5) databases created by the International Agency for Research on Cancer (IARC). Researchers analyzed the change in incidence rates over the past 20 years; 1983-87 through 1998-2002. They found colorectal cancer incidence rates for both males and females increased for 27 of 51 cancer registries considered in the analysis between 1983-87 and 1998-2002. The increases were more prominent for men than for women. Some of the increases were dramatic. For example, in Slovenia, colorectal cancer incidence increased 70 percent among men and 28 percent among women. In Miyagi, Japan, rates rose 92 percent among men and 47 percent among women. The researchers also observed substantial regional and ethnic variations in colorectal cancer incidence trends within countries such as Japan, Israel, and Singapore. The United States was the only country where colorectal cancer incidence rates declined in both males and females. The authors say the increase in colorectal cancer in economically transitioning countries may reflect the adoption of western lifestyles and behaviors. Many of the established and suspected modifiable risk factors for colorectal cancer, including obesity, physical inactivity, smoking, heavy alcohol consumption, a diet high in red or processed meats, and inadequate consumption of fruits and vegetables, are also factors associated with economic development or westernization. The authors say male colorectal cancer incidence rates in the Czech Republic, Slovakia, and Japan have not only exceeded the peak incidence observed in the United States and other long-standing developed nations, but continue to increase. An accompanying editorial by Asad Umar and Peter Greenwald of the Division of Cancer Prevention of the National Cancer Institute calls the rising rates "alarming," saying "this increase points toward a failed early detection and prevention strategy as well as failure to address lifestyle and dietary challenges of urbanization that affect most of the globe." Article: "International Trends in Colorectal Cancer Incidence Rates." Cancer Epidemiol Biomarkers Prev 2009;18(6):1688. Editorial: "Alarming Colorectal Cancer Incidence Trends: A Case for Early Detection and Prevention." Cancer Epidemiol Biomarkers Prev 2009;18(6):1672 - 3 David Sampson American Cancer Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):